Clinical Study
Comparison of the Efficacy of Intravitreal Aflibercept and Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion
Figure 1
Changes of best-corrected visual acuity from baseline to month 12 in patients with macular edema secondary to branch retinal vein occlusion treated by intravitreal aflibercept or bevacizumab.